Oncology

New study reveals how iron levels influence FLASH radiotherapy’s dual effect of tumour control and normal tissue protection.

A longitudinal study of 188 cervical cancer patients undergoing brachytherapy revealed that multidimensional fatigue slightly increased during treatment, peaking after five sessions, then significantly decreased one month post-treatment.

A new study reveals circulating tumour DNA correlates with tumour volume in metastatic pancreatic cancer, particularly with liver metastases.

Oral bacteria and fungi have been identified as risk factors for the development of pancreatic cancer, making them potential non-invasive biomarkers for identifying individuals at high risk.

Researchers have uncovered a central role for Tropomodulin-2 (TMOD2) in promoting colorectal cancer (CRC) progression and liver metastasis.

Researchers are making progress in the fight against neuroblastoma (NB), a challenging childhood tumour known for its resistance to chemotherapy.

A groundbreaking new tool, Ovatools, is set to transform ovarian cancer diagnosis in UK primary care by providing personalised risk scores that combine CA125 blood test results with a patient’s age.

A recent study introduces an advanced ex vivo 3D micro-tumour testing platform that accurately forecasts individual patient response to chemotherapy, potentially revolutionizing personalized treatment decisions.